Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Segment Reporting Information, by Segment

The following table presents a summary of the revenues and adjusted EBITDA of our three operating segments for the years ended December 31, 2022, 2021, and 2020:


	Year Ended December 31,
(In thousands)	2022		2021		2020
Revenues:
RCM	$	179,870	$	131,242	$	107,431
EHR
Recurring revenue
Acute Care EHR	$	109,340	$	108,440	$	105,597
Post-acute Care EHR	$	15,384	$	16,472	$	16,272
Total recurring EHR revenues	124,724		124,912		121,869
Non-recurring revenue
Acute Care EHR	$	13,138	$	16,939	$	29,173
Post-acute Care EHR	$	1,961	$	1,258	$	1,912
Total non-recurring EHR revenues	15,099		18,197		31,085
Total EHR revenue	139,823		143,109		152,954
Patient engagement	6,955		6,278		4,103
Total revenues	$	326,648	$	280,629	$	264,488

Adjusted EBITDA by Segment:
RCM	36,242		30,211		22,780
EHR	19,091		23,061		21,488
Patient engagement	566		(595)		(881)
Total adjusted EBITDA	$	55,899	$	52,677	$	43,387

Reconciliation Of Net Income From Continuing Operations To Adjusted Income (Loss) From Before Interest, Taxes, Depreciation And Amortization

The following table reconciles net income to adjusted EBITDA:


	Year Ended December 31,
(In thousands)	2022		2021		2020
Net income, as reported	$	15,867	$	18,430	$	14,246
Deferred revenue and other acquisition-related adjustments	109		747		—
Depreciation expense	2,443		2,156		1,790
Amortization of software development costs	3,484		931		118
Amortization of acquisition-related intangibles	17,403		13,786		11,421
Stock-based compensation	5,173		5,457		7,005
Severance and other non-recurring charges	4,504		4,892		1,999
Interest expense and other, net	5,267		1,632		2,270
Gain on contingent consideration	(565)		—		—
Provision for income taxes	2,214		4,646		4,538
Total adjusted EBITDA	$	55,899	$	52,677	$	43,387